Cargando…
Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons
Mutations in the MECP2 gene cause the neurodevelopmental disorder Rett syndrome (RTT). Previous studies have shown that altered MeCP2 levels result in aberrant neurite outgrowth and glutamatergic synapse formation. However, causal molecular mechanisms are not well understood since MeCP2 is known to...
Autores principales: | Sampathkumar, Charanya, Wu, Yuan-Ju, Vadhvani, Mayur, Trimbuch, Thorsten, Eickholt, Britta, Rosenmund, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108590/ https://www.ncbi.nlm.nih.gov/pubmed/27782879 http://dx.doi.org/10.7554/eLife.19374 |
Ejemplares similares
-
Importin α5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1
por: Panayotis, Nicolas, et al.
Publicado: (2018) -
Differential pH Dynamics in Synaptic Vesicles From Intact Glutamatergic and GABAergic Synapses
por: Herman, Melissa A., et al.
Publicado: (2018) -
SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression
por: Zocchi, Loredana, et al.
Publicado: (2012) -
Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders
por: Meng, Xiangling, et al.
Publicado: (2016) -
Sustained effects of rapidly-acting antidepressants require BDNF-dependent MeCP2 phosphorylation
por: Kim, Ji-Woon, et al.
Publicado: (2021)